improved-an observation confirmed by more recent studies. 4, 5 Other research has shown that, while nutritional deterioration was related to disease status, reduced energy and protein intakes and weight loss were also independently associated with impaired QoL. An emerging area of research, QoL has always been a prime concern of cancer patients themselves. 1, 6, 7 This article will focus on the role of the registered dietician (RD) on the oncology team, identifying and implementing therapeutic nutritional interventions that both effectively stabilize weight and maintain and rebuild LBM. Planning effective strategies entails triaging patients to determine the source of their weight loss, allowing the team to target the specific underlying factors. Ultimately, there must be differentiation between patients experiencing symptom-related weight loss and those with metabolic abnormalities that define cachexia.
Calories, Protein, and Lean Body Mass
Adequate calories to provide the energy needed for normal function is the body's top priority, and protein will be burned as energy when calories are grossly inadequate-a common consequence of cancer and treatment-related symptoms such as anorexia, taste changes, and early satiety. These symptoms are present in up to 80% of patients with gastrointestinal (GI) tumors and 60% of lung cancer patients, but much less frequently with breast or hematological malignancies. 8 Muscle/LBM is directly affected by protein intake in the diet, replenishing the amino acids lost during the fasting state between meals. Optimal intake that supports muscle function is estimated at 1.8g protein/kg/day; this is met by the average American diet, but protein is one of the most common deficits when intake is limited. 9 Exercise also improves function, with the most benefit from early interventions to limit loss of LBM.
The stressed state seen in advanced cancer results in far greater demand for amino acids released from muscle breakdown than occurs in fasting alone. 10 When dietary protein is not spared or is inadequate in the diet, muscle catabolism provides the amino acids to maintain the protein mass of critical organs and tissues. It is also used to maintain normal plasma glucose concentration, which ensures energy is available to essential organs. In addition, muscle reserves support the production of other critically essential proteins-i.e.
albumin-though typically at suboptimal levels for conservation of LBM. 
Nutritional Solutions/Supplements for
Symptom-related Weight Loss
Several useful resources are available outlining the baseline assessments, ongoing surveillance, high calorie interventions, and patient education needed to address the symptoms limiting oral intake. 13, 14 These offer the RD effective treatment strategies when weight loss is clearly proportionate to calorie deficit and weight losses are primarily from fat stores.
Interventions include:
• addressing barriers to eating, such as nausea, diarrhea, mucositis, reflux, and depression;
• establishing a schedule with small, frequent meals and snacks;
• maximizing caloric density; and
• using fluids with calories, including oral nutritional supplements.
The use of fluids with calories is a critical component, since their consumption requires less effort than is needed for chewing/swallowing solid foods, they rarely stimulate the gag reflex, and may speed gastric 
Nutritional Solutions/Supplements for

Tumor-mediated Cachexia
Although weight loss in cachexia is often attributed to anorexia, it involves more than a simple caloric deficit and can occur in the absence of anorexia. 15 The energy deficit, if any, does not account for the amount of muscle mass and weight that is lost, often early in the disease course.
Skeletal muscle and fat are lost at almost equivalent rates, impacting strength and QoL.
Tumor-related metabolic factors create changes in the metabolism of protein, carbohydrate, and fat that result in muscle wasting, which can precede any decline in intake. Targets for anticachectic therapies have included:
• proteolysis-inducing factor (PIF), which is responsible for targeting muscle mass for degradation, leading to extensive loss of LBM;
• lipid-mobilizing factor, leading to increased lipid breakdown and energy losses through thermo genesis; and
• cytokine-triggered inflammatory response: tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1, IL-6.
Detailing these factors and their implications for nutritional status are beyond the scope of this article, but they have been reviewed elsewhere. 14, 16 Nutritional counseling and the addition of traditional oral supplements did not improve weight in Ovesen's study of cachectic patients. 17 Assessing patients for loss of muscle mass is frequently overlooked by dieticians as it has typically been ignored in our formal education, but it is essential to our decision-making with regard to cancer patients.
Realistically, the required equipment is frequently unavailable even for those trained in bioelectrical impedance analysis or other methods used to directly measure LBM. In spite of this, losses of LBD can be accurately documented and even predicted by screening for the predictors and physical penalties associated with this loss, including:
• rapid weight loss of >2lb per week, accompanied by the additional predictors detailed below;
• visible losses of muscle mass, such as temporal wasting or wasting of arm/leg muscle-a video demonstrating physical assessment as part of a patient-generated subjective global assessment (PGSGA) is available through the American Dietetics Association; 21 • weakness, with loss of strength;
• fatigue, as protein reserves are less able to stabilize blood sugar levels;
• decreases on performance or functional status scales; and
The combination of oral supplements with individual counseling is the most effective therapy…
• alterations in serum proteins with an elevated C-reactive protein and declines in albumin levels. improvements during the study, but the benefits were not sustained three months later. The control group lost ground throughout. 25 Individualized, sequential counseling takes into account personal preferences and patterns and addresses specific barriers to intake. Oral supplements in isolation temporarily increased intake but did not sustain that improvement over time, possibly due to the taste fatigue that can develop with repeated consumption or, alternatively, due to unaddressed barriers. The fact that any weight gain was achieved is counter to an earlier study 17 and may reflect the cancer-specific QoL scale used in the recent studies, or improvements in the oral supplements available or in the quality and frequency of nutritional counseling.
Nutritional Counseling Improves Outcomes
Ideally, the combination of oral supplements with individual counseling is the most effective therapy, with periodic counseling to sustain interventions that are working for the patient while addressing any new barriers that arise. Certainly, oral supplements are an integral part of the practice of most oncology dieticians, with the most successful interventions including a manipulation of everyday foods, rotation of oral supplements, and management of symptoms that interfere with eating. Identifying the appropriate supplement for each patient has always been our responsibility, and options that target metabolic abnormalities offer new tools. • HMB reverses muscle breakdown 2 and builds lean body mass 3 • Arginine improves nitrogen balance and promotes wound healing 4, 5 • Glutamine supports gut integrity 6 and preserves muscle glutamine
Recommendations on the Appropriate Use of Supplements in Cachexia
Refreshing flavors, rejuvenating results
Great-tasting orange and grape flavors help ensure patient adherence with JUVEN.
• • JUVEN patients continued to gain LBM throughout the 24-week study †1 Rebuilding Muscles. Rebuilding Lives. 
